New research in breast cancer is ongoing all around the world …
As part of Breast Cancer Awareness month Purdue University is …
Advertisement
Md. company to study cancer medicine feasibility
Idea uses gold nanoparticles to carry cancer meds
Updated: Thursday, 27 Dec 2012, 4:52 PM EST
Published : Thursday, 27 Dec 2012, 4:52 PM EST
ROCKVILLE, Md. (AP) - A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca.
CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday.
The two companies will work together to see whether they can transmit cancer drugs on extremely small gold particles.
CytImmune works in developing nanomedicine, which uses tiny particles of gold to carry cancer therapies directly to the site of the disease. The company says gold nanoparticles have been used safely since the 1930s to treat patients with rheumatoid arthritis.
Dr. Lawrence Tamarkin, CytImmune's CEO, says the partnership aims to combine CytImmune's nanotechnology research with AstraZeneca's oncology compound to create a cancer therapy that may be widely applicable to solid tumors.
Comments WLFI.com is migrating to a more stable commenting system called DISQUS. This system is used by CNN, TIME, FOX News, numerous blogging sites and has over 75 Million registered users. Unfortunately we can't migrate our current user accounts to this new system.
To sign up for a DISQUS account, click the DISQUS button just below and to the right and then click Login.
DISQUS lets you login with several different options, including Facebook, Google, Twitter, Yahoo or OpenID. We expect it to allow more conversation and better moderation. If you have any questions, please feel free to comment below.
Email This
Print This
View Story on a Single PageAdvertisement
Advertisement